NAGARAJU BALAGA's Colleagues at Vasudha Pharma Chem. Ltd
N Rao
N. Srinivasa Rao Msc, Head Manufacturing Works /Plant Head, 25 years experience in API Bulk Drugs
NAGARAJU BALAGA's Contact Details
["918333040321","914044763666","7036444495","914044763666","914044763666","914044754545","2381498723811576","04044763666","04023812046","914023812046","7730861182","0995005621","914044763666","919553969696","914023812046","8985456773","914023395515","6696/44763636","919346510183","04023814987","00914044763666","04044763666","914023812046","2026993901","914023711717","9123812046","9348570999","9391316878","04044754545","914023812046","914023812046","914023195480"]
Vasudha Pharma Chem. Ltd
NAGARAJU BALAGA's Company Details
VPCL was incorporated as a public limited company under the Companies Act, 1956 at Hyderabad in the state of Andhra Pradesh, India during the year 1994 - 95. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients ( APIs ), Pharma Intermediates for catering to the domestic as well as international market.Initially, the focus was on development of cost effective processes for several intermediates related to piperidone & piperidine derivatives. By 2003 -04, the company gained world class expertise and became the largest manufacturer of piperidone & piperidine derivatives in the world. Subsequently, the company forward integrated from intermediates of piperidone & piperidine derivatives to APIs and later on diversified into large product portfolio of about 25 APIs spreading across several therapeutic areas.First manufacturing facility at Hyderabad,AP, has been set up in 1997 - 98 and subsequently upgraded to cGMP standards in 2006 - 07. Second manufacturing facility has been set up in Jawaharlal Nehru Pharma City, Visakhapatnam, AP with WHO-GMP standards and commenced operation in FY 2007-08. Third manufacturing facility has also been set up at Jawaharlal Nehru Pharma City, Visakhapatnam and commenced operation in FY 2010-11.The company has already obtained WHO GMP certification for all its leading APIs and obtained COS for three of its APIs. The company has also filed DMFs with USFDA and EDQM for three of its APIs.